Shyft Analytics bolsters RWE solutions

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Utah778)
(Image: Getty/Utah778)

Related tags: RWE, RWD, Medidata, Data management, Data collection, Data

Medidata’s Shyft expands its real-world data services to meet the various real-world evidence needs of its customer’s organizations, says new VP.

Shyft Analytics, a Medidata company, has expanded the real-world evidence (RWE) components of its solution platform and added to its RWE team, which will be led by Aaron Galaznik, MD, and Bruno Lempernesse.

The team serves as a dedicated resource for customers’ data analytics and evidence generation needs​, providing services including data due diligence, evidence strategy, analytics best practices consulting, as well as full study execution.

Galaznik, the new head of research, has held leadership roles at Takeda and Pfizer working to develop the companies’ real-world data (RWD) initiatives.

Previously the CEO of Inflexxion, Lempernesse in his new role as the vice president and general manager of the Shyft RWE solutions team said the company has found varying level of maturity with regards to RWE teams and capabilities at life science organizations.

“Some have fully-staffed RWE departments capable of managing large-scale real-world data sets, performing rigorous data analysis, and generating outcomes studies,”​ he told us. “But more often, we come across organizations that require deep expertise to support the various RWE-related needs from across the organization.”

Lempernesse said, “The expansion of this capability at Shyft allows us to provide value-added services to the industry, regardless of their current in-house capabilities.”

Medidata acquired Shyft Analytics in 2018​ for $195m, creating a platform that combines clinical development with commercial and real-world data analytics.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars